[CAS NO. 1221713-92-3]  NPS-1034

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1221713-92-3]

Catalog
SLK-S7669
Brand
Selleck
CAS
1221713-92-3

DESCRIPTION [1221713-92-3]

Overview

MDLMFCD29905447
Molecular Weight551.54
Molecular FormulaC31H23F2N5O3
SMILESO=C(C1=C(C)N(C)N(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C5C(NC=C5C6=CC=CC=C6)=NC=C4)C(F)=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.8131 mL9.0655 mL18.1311 mL
5 mM0.3626 mL1.8131 mL3.6262 mL
10 mM0.1813 mL0.9066 mL1.8131 mL
50 mM0.0363 mL0.1813 mL0.3626 mL

Description

NPS-1034 is a dual inhibitor with of 48 nM and 10.3 nM, respectively.

Targets

Axl [1]
(Cell-free assay)
Met [1]
(Cell-free assay)
10.3 nM48 nM

In vitro

In HCC827/GR cells, NPS-1034 does not show significant antiproliferative effects, while overcomes gefitinib resistance by inhibiting the phosphorylation of MET, Akt, and Erk. In H820 cells, NPS-1034 enhances sensitivity to EGFR-TKIs. In HCC78 cells, NPS-1034 inhibits ROS1 activity and cell proliferation. In addition, a combination of gefitinib and NPS-1034 enhances cell death by inducing caspase-3 and PARP-1 cleavage. NPS-1034 inhibits the viability of the MKN45 and SNU638 cell lines, which highly express the MET gene and p-MET, with IC50 of 112.7 and 190.3 nmol, respectively.

In vivo

In SCID mice bearing HCC827/GR tumor xenografts, NPS-1034 (10 mg/kg, p.o.) decreases tumor growth, and the combination of gefitinib and NPS-1034 results in enhanced tumor growth inhibition via the inhibition of tumor proliferation and the induction of apoptosis. In nude mice bearing MKN45 xenograft tumors, NPS-1034 (30 mg/kg, p.o.) decreases tumor growth through the inhibition of angiogenesis and the promotion of apoptosis.